StonvexLoading…
StonvexCore line items from ARTW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 | Q1 2025 2025-02-28 |
|---|---|---|---|---|
Revenue | $6.64M | $17.91M | $11.48M | $5.14M |
Operating Income | $330.02K | $857.87K | $513.14K | $2.48K |
Net Income | $196.44K | $1.68M | $1.43M | $-55.76K |
EPS (Diluted) | $0.04 | $0.33 | $0.28 | $-0.01 |
Total Assets | $24.56M | $21.82M | $20.88M | $21.00M |
Total Liabilities | $11.02M | $7.90M | $7.26M | $8.92M |
Cash & Equivalents | $2.94K | $5.96K | $4.53K | $4.13K |
Free Cash Flow OCF − CapEx | $-28.02K | $-489.76K | $1.04M | $-184.53K |
Shares Outstanding | 5.14M | 5.09M | 5.07M | 5.05M |